Notice Number: NOT-AI-15-037
Key Dates
Release Date: June 1, 2015
Related Announcements
RFA-AI-15-029
Issued by
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
Purpose
The purpose of this Notice is to make the following corrections to RFA-AI-15-029 "Martin Delaney Collaboratories for HIV Cure Research (UM1)".
Part 2. Section III. 1. Eligible Applicants
Eligible Organizations
Current Language:
Other
- Independent School Districts
- Public Housing Authorities/Indian Housing Authorities
- Native American Tribal Organizations (other than Federally recognized tribal governments)
- Faith-based or Community-based Organizations
- Regional Organizations
- Non-domestic (non-U.S.) Entities (Foreign Institutions)
Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Revised Language:
Other
- Independent School Districts
- Public Housing Authorities/Indian Housing Authorities
- Native American Tribal Organizations (other than Federally recognized tribal governments)
- Faith-based or Community-based Organizations
- Regional Organizations
Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Part 2. Section III. 3. Additional Information on Eligibility
Number of Applications
Current Language:
Applicant organizations may submit more than one application, provided that each application is scientifically distinct.
The NIH will not accept duplicate or highly overlapping applications under review at the same time. This means that the NIH will not accept:
- A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.
- A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
- An application that has substantial overlap with another application pending appeal of initial peer review (see NOT-OD-11-101).
Revised Language:
Only one application per institution (normally identified by having a unique DUNS number or NIH IPF number) is allowed. However, a given institution may receive funds through subawards from more than one application.
The NIH will not accept duplicate or highly overlapping applications under review at the same time. This means that the NIH will not accept:
- A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.
- A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
- An application that has substantial overlap with another application pending appeal of initial peer review (see NOT-OD-11-101).
Part 2. Section V.1. Criteria
Additional Review Considerations
Current Language:
Applications from Foreign Organizations
Reviewers will assess whether the project presents special opportunities for furthering research programs through the use of unusual talent, resources, populations, or environmental conditions that exist in other countries and either are not readily available in the United States or augment existing U.S. resources.
Revised Language:
Applications from Foreign Organizations
Not Applicable
All other aspects of this FOA remain the same.
Inquiries
Please direct all inquiries to:
Diane Lawrence, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3202
Email: [email protected]
Jeymohan Joseph, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 240-627-3869
Email: [email protected]
Vishnudutt Purohit, DVM, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-594-5753
Email: [email protected]
May Wong, Ph.D.
National Institute of National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1431
Email: [email protected]
and Human Services (HHS)
